Tado Gilio laboratorija - Company finances
|
EUR
|
2022
From: 2022-01-14
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 118,030 | 317,236 | 302,730 | 235,685 |
| Profit before tax | 25,881 | 31,544 | -8,775 | 1,540 |
| Net profit | 25,881 | 31,544 | -8,775 | 1,448 |
| Equity | 25,882 | 57,426 | 49,325 | 47,649 |
| Liabilities | 9,683 | 10,502 | 4,747 | 9,343 |
| Non-current assets | 20,071 | 34,254 | 32,502 | 30,194 |
| Current assets | 15,494 | 33,674 | 21,570 | 26,798 |
| Total assets | 35,565 | 67,928 | 54,072 | 56,992 |
|
Taxes paid
|
||||
| STI taxes | - | 11,695 | 14,079 | 7,004 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +168.8% | -4.6% | -22.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 72.8% | 46.4% | -16.2% | 2.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 54.9% | -17.8% | 3.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 21.9% | 9.9% | -2.9% | 0.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 21.9% | 9.9% | -2.9% | 0.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.2 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 59,015 | 158,618 | 259,475 | 235,685 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Tado Gilio laboratorija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-25 | 2026-06-01 | 1004.45 |
| 2026-05-24 | 2026-05-24 | 944.51 |
| 2026-05-17 | 2026-05-23 | 1592.14 |
| 2026-05-13 | 2026-05-14 | 962.44 |
| 2026-05-05 | 2026-05-12 | 1672.62 |
| 2026-05-04 | 2026-05-04 | 372.59 |
| 2026-05-03 | 2026-05-03 | 372.59 |
| 2026-04-24 | 2026-04-29 | 939.78 |
| 2026-04-20 | 2026-04-23 | 1235.36 |
| 2026-04-13 | 2026-04-15 | 605.66 |
| 2026-04-01 | 2026-04-12 | 1315.84 |
| 2026-03-29 | 2026-03-31 | 1235.36 |
| 2026-03-27 | 2026-03-27 | 1883.03 |
| 2026-03-23 | 2026-03-26 | 1235.36 |
| 2026-03-20 | 2026-03-22 | 1235.36 |
| 2026-03-17 | 2026-03-19 | 1883.03 |
| 2026-03-15 | 2026-03-16 | 1253.33 |
| 2026-03-03 | 2026-03-11 | 1963.51 |
| 2026-03-02 | 2026-03-02 | 1883.03 |
| 2026-03-01 | 2026-03-01 | 2530.70 |
| 2026-02-18 | 2026-02-28 | 2530.70 |
| 2026-02-12 | 2026-02-17 | 2247.91 |
| 2026-02-03 | 2026-02-11 | 2611.18 |
| 2026-02-02 | 2026-02-02 | 2530.70 |
| 2026-02-01 | 2026-02-01 | 2530.70 |
| 2026-01-16 | 2026-01-31 | 3178.37 |
| 2026-01-14 | 2026-01-15 | 2549.38 |
| 2026-01-01 | 2026-01-13 | 3250.83 |
| 2025-12-23 | 2025-12-30 | 3178.38 |
| 2025-12-16 | 2025-12-22 | 3826.05 |
| 2025-12-10 | 2025-12-15 | 3197.06 |
| 2025-12-02 | 2025-12-09 | 3898.51 |
| 2025-12-01 | 2025-12-01 | 3826.06 |
| 2025-11-18 | 2025-11-30 | 4473.73 |
| 2025-11-12 | 2025-11-17 | 3930.51 |
| 2025-11-03 | 2025-11-11 | 4546.18 |
| 2025-11-02 | 2025-11-02 | 4546.18 |
| 2025-11-01 | 2025-11-01 | 5193.85 |
| 2025-10-16 | 2025-10-31 | 5121.40 |
| 2025-10-14 | 2025-10-15 | 4492.41 |
| 2025-10-02 | 2025-10-13 | 5193.86 |
| 2025-10-01 | 2025-10-01 | 5193.86 |
| 2025-09-30 | 2025-09-30 | 5121.41 |
| 2025-09-16 | 2025-09-29 | 5769.08 |
| 2025-09-11 | 2025-09-15 | 5140.09 |
| 2025-09-10 | 2025-09-10 | 5841.54 |
| 2025-09-07 | 2025-09-09 | 5841.54 |
| 2025-09-02 | 2025-09-03 | 5841.54 |
| 2025-09-01 | 2025-09-01 | 5769.09 |
| 2025-08-31 | 2025-08-31 | 5769.09 |
| 2025-08-28 | 2025-08-29 | 6416.76 |
| 2025-08-22 | 2025-08-27 | 5769.09 |
| 2025-08-19 | 2025-08-21 | 6416.76 |
| 2025-08-11 | 2025-08-18 | 5989.65 |
| 2025-08-01 | 2025-08-10 | 6489.21 |
| 2025-07-24 | 2025-07-31 | 6416.76 |
| 2025-07-16 | 2025-07-23 | 7064.43 |
| 2025-07-11 | 2025-07-15 | 6632.52 |
| 2025-07-02 | 2025-07-10 | 7136.88 |
| 2025-07-01 | 2025-07-01 | 7136.88 |
| 2025-06-27 | 2025-06-30 | 7064.43 |
| 2025-06-17 | 2025-06-26 | 7712.10 |
| 2025-06-11 | 2025-06-16 | 7083.11 |
| 2025-06-08 | 2025-06-09 | 7784.56 |
| 2025-06-03 | 2025-06-04 | 7784.56 |
| 2025-06-02 | 2025-06-02 | 7712.11 |
| 2025-06-01 | 2025-06-01 | 7712.11 |
| 2025-05-31 | 2025-05-31 | 7712.11 |
| 2025-05-28 | 2025-05-30 | 8359.77 |
| 2025-05-16 | 2025-05-27 | 8359.77 |
| 2025-05-12 | 2025-05-15 | 7730.78 |
| 2025-05-04 | 2025-05-11 | 8432.23 |
| 2025-04-16 | 2025-04-30 | 1861.27 |
| 2025-04-01 | 2025-04-13 | 12.58 |
| 2025-03-04 | 2025-03-11 | 12.59 |
| 2025-03-01 | 2025-03-02 | 12.59 |
| 2025-02-01 | 2025-02-09 | 12.59 |
| 2025-01-02 | 2025-01-09 | 4.65 |
| 2024-12-05 | 2024-12-15 | 4.66 |
| 2024-12-03 | 2024-12-04 | 4004.82 |
| 2024-11-18 | 2024-12-02 | 3940.32 |
| 2024-11-14 | 2024-11-17 | 3311.33 |
| 2022-12-01 | 2022-12-07 | 50.95 |
| 2022-08-02 | 2022-08-31 | 50.95 |
Tado Gilio laboratorija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-02 | 2025-03-12 | 4.18 |
| 2025-02-19 | 2025-03-01 | 3.78 |
| 2025-02-16 | 2025-02-18 | 390.64 |
| 2025-02-14 | 2025-02-15 | 390.44 |
| 2025-02-13 | 2025-02-13 | 390.45 |
| 2025-02-07 | 2025-02-12 | 467.78 |
| 2025-01-09 | 2025-01-10 | 464.53 |
| 2024-09-22 | 2024-10-22 | 1.32 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Tado Gilio laboratorija, MB (code 305981841) is a Lithuanian small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In the latest financial year 2025, the company generated revenue of €235.7K and net profit of €1.4K, corresponding to a profit margin of 0.6%. Revenue declined by 22.1% year on year and by 25.7% over two years, showing a clear downward trend from €317.2K in 2023 to €302.7K in 2024 and then to €235.7K in 2025. Profitability weakened in 2024, when the company reported a net loss of €8.8K, before returning to a small profit in 2025. At the end of 2025, total assets were €57.0K, equity €47.6K and liabilities €9.3K, with an equity ratio of 83.6% and debt-to-equity of 0.20. Asset turnover was 4.14x, ROE 3.0% and ROA 2.5%. Revenue per employee was €235.7K and profit per employee €1.4K.